CS MEDICA A/S: Notice of Annual General Meeting
Tuesday, March 31, 2026 at 15:00 CET
at the Company’s address:
Indiakaj 10, 2nd floor
2100 Copenhagen Ø, Denmark
Agenda:
- Election of Chairman of the Meeting.
- Presentation of the Annual Report.
- Resolution concerning the appropriation of losses as recorded in the Annual Report.
- Election of members to the Board of Directors.
- Election of the Company’s auditor.
- Any other business.
The total number of votes as of the date of this notice is 19,026,344.
Additional Information:
- Annual Report
The annual report for the financial year 1 October 2024 – 30 September 2025 is currently under preparation and review by the Company’s auditor and is therefore not expected to be available within the statutory deadline prior to the Annual General Meeting.
A preliminary version of the annual report is available on the Company’s website for information purposes: https://www.cs-medica.com/investor/financial-reports/
Accordingly, the annual report will be presented at the Annual General Meeting but will not be adopted. Adoption of the annual report will take place at an extraordinary general meeting to be convened as soon as practicable once the annual report has been finalized.
- Appropriation of Losses
This item will be resolved at a subsequent general meeting in connection with the adoption of the annual report. - Election of Members to the Board of Directors
The Board of Directors proposes the election of Jens Hagelskjær. - Election of Auditor
The Board of Directors proposes that Christensen Kjærulff Statsautoriseret Revisionsaktieselskab be re-elected as the Company’s auditor.
Participation and Registration:
To attend the Annual General Meeting, please register by email to: info@cs-medica.com
Registration deadline: March 21, 2026
Only shareholders registered on this date are entitled to attend and vote.
Proxy and Postal Voting:
Shareholders may attend the Annual General Meeting by proxy. Proxy and postal voting forms must be submitted no later than March 21, 2026 at 23:59 CET, in accordance with Section 5.9 of the Articles of Association.
The relevant forms are available on the Company’s website: www.cs-medica.com
Nominee-registered Shares:
Shareholders holding shares through a nominee must ensure registration in the share register by March 21, 2026.
Shareholder Questions:
Questions may be submitted in writing prior to the AGM or raised during the meeting. Answers will be provided at the meeting or within two weeks thereafter.
For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/
About CS MEDICA A/S
Founded in 2011, CS MEDICA is a Danish MedTech company specializing in CBD-infused treatments for autoimmune and stress-related conditions, including arthritis, psoriasis, and pain management. Operating at the intersection of the pharmaceutical and cosmetics industries, CS MEDICA delivers clinically supported products with fewer side effects, offering competitive and accessible alternatives. With MDR-approved products, cutting-edge R&D, and the benefits of CBD, the company provides innovative, safe, and effective solutions. Its capital-light business model and trusted European production partners further enhance its ability to offer high-quality treatments, setting CS MEDICA apart in the MedTech sector.
